Objectives: To develop and test a convolutional neural network model for automated segmentation of complicated cystic renal masses (cCRMs) on MRI. Methods: This multicenter retrospective study analysed 210 cCRMs between October 2019 and May 2021, divided into training/internal validation (n = 150, Institution 1) and test sets (n = 60, Institutions 2-4). Comparative 3D V-Net and U-Net models were developed across 7 MRI sequences (T2-weighted, diffusion-weighted, apparent diffusion coefficient maps, unenhanced T1-weighted, and enhanced corticomedullary, nephrographic, and excretory phases images). A total of 14 models were developed, and 7 pairwise comparisons were performed between the 3D V-Net and U-Net models. Segmentation performance was evaluated using Dice similarity coefficient (DSC) and Hausdorff distance (HD), with subgroup analysis of small cCRMs (<= 40 mm). Results: In the test set, the excretory-phase V-Net (EPV-Net model) showed the highest DSC, and perform better than the corresponding U-Net (EPU-Net model) across all cCRMs (DSC: 0.74 +/- 0.05 vs 0.70 +/- 0.06, P < .001; HD: 27.41 +/- 7.44 mm vs 39.18 +/- 11.07 mm, P < .001) and the 35 small cCRMs subgroup (DSC: 0.74 +/- 0.05 vs 0.70 +/- 0.06, P < .001; HD: 27.48 mm +/- 6.32 vs 38.72 +/- 10.69 mm, P < .001). Conclusions: The 3D EPV-Net model demonstrated good segmentation accuracy, even for small lesions, supporting its clinical utility for cCRMs evaluation. Advances in knowledge: This automated approach may streamline workflow compared to manual segmentation in cCRMs assessment.